Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Paracrine Induction of Cardiomyogenic Differentiation in Patient-Specific MSCs Using Conditioned Medium from iPSC-CMs.

Biomedicines·2026

Same author

Ex Vivo Hypothermic Perfusion Enables 48-Hour Heart Preservation and Bench-Top Functional Recovery via Normothermic Reperfusion in a Porcine Model.

Journal of the American Heart Association·2026

Same author

Refining fibroblast-to-cardiomyocyte transdifferentiation protocols to explore emergent self-organization in cardiac cultures.

PloS one·2026

Same author

Precision Glyco-Modulated GcMAF2.0 Targets CLEC10A to Bidirectionally Re-Wire Macrophage States: Cross-Species Evidence, Mechanistic Omics and Translational Horizons.

Immunology·2026

Same author

Single intramuscular injection of self-amplifying RNA of <i>Nppa</i> to treat myocardial infarction.

Science (New York, N.Y.)·2026

Same author

Adjunct EF-M2 therapy improves clinical activity, steroid-sparing, and macrophage-linked biomarkers in feline chronic enteropathy: A randomized, double-blind, and placebo-controlled trial.

Veterinary world·2026

Search research articles

Related Experiment Video

Updated: May 8, 2026

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

Published on: April 13, 2018

Stem cell therapy for electrophysiological disorders.

Evgeny Pokushalov¹, Alexander Romanov, Jonathan S Steinberg

¹State Research Institute of Circulation Pathology, 15 Rechkunovskaya St., Novosibirsk, Russia, 630055. E.Pokushalov@gmail.com

Current Cardiology Reports

|August 20, 2013

Summary

This summary is machine-generated.

Stem cell therapies show promise for treating cardiovascular diseases by regenerating heart cells. Further research is needed to understand their antiarrhythmic potential and ensure safety before widespread clinical use.

More Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

Related Experiment Videos

Last Updated: May 8, 2026

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

Published on: April 13, 2018

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

Area of Science:

Regenerative medicine
Cardiology
Stem cell biology

Background:

Cardiovascular diseases are a primary global cause of death.
Adult cardiomyocytes have limited regenerative capacity.
Cell- and gene-based therapies offer novel approaches for myocardial repair.

Purpose of the Study:

To review stem cell therapy mechanisms for antiarrhythmic treatment.
To discuss the potential of induced pluripotent stem cell-derived cardiomyocytes.
To evaluate early clinical results of stem cell-based cardiac therapies.

Main Methods:

Review of existing literature on stem cell therapies for cardiovascular diseases.
Analysis of mechanisms underlying stem cell function in myocardial repair.
Examination of electrophysiological and contractile properties of stem cell-derived cardiomyocytes.

Main Results:

Stem cell therapies present potential advantages and disadvantages for treating electrophysiological disorders.
Human induced pluripotent stem cell-derived cardiomyocytes are of significant interest for personalized medicine.
Understanding stem cell electrophysiology is crucial for therapeutic application.

Conclusions:

Stem cell therapy is a promising strategy for antiarrhythmic treatment in cardiovascular diseases.
Further investigation into stem cell function and safety is essential.
Early clinical data suggests potential but requires more extensive study.